ArticleApplied and environmental microbiology2012
Large crystal toxin formation in chromosomally engineered Bacillus thuringiensis subsp. aizawai due to σE accumulation.
Article in Applied and environmental microbiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 8 citations in OpenAlex.
- Chitinases ofFrontiers in microbiology · 2019Review
- Bacillus thuringiensis subsp. kurstaki HD1 as a factory to synthesize alkali-labile ChiA74∆sp chitinase inclusions, Cry crystals and spores for applied use.Microbial cell factories · 2014Article
- Bacillus subtilis strain engineered for treatment of soil-transmitted helminth diseases.Applied and environmental microbiology · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Seven distinct Bacillus thuringiensis subsp. aizawai integrants were constructed that carried the chitinase (chiBlA) gene from B. licheniformis under the control of the cry11Aa promoter and terminator with and without p19 and p20 genes. The toxicity of B. thuringiensis subsp. aizawai integrants against second-instar Spodoptera litura larvae was increased 1.8- to 4.6-fold compared to that of the wild-type strain (BTA1). Surprisingly, the enhanced toxicity in some strains of B. thuringiensis subsp. aizawai integrants (BtaP19CS, BtaP19CSter, and BtaCAT) correlated with an increase in toxin formation. To investigate the role of these genes in toxin production, the expression profiles of the toxin genes, cry1Aa and chiBlA, as well as their transcriptional regulators (sigK and sigE), were analyzed by quantitative real-time RT-PCR (qPCR) from BTA1, BtaP19CS, and BtaCAT. Expression levels of cry1Aa in these two integrants increased about 2- to 3-fold compared to those of BTA1. The expression of the transcription factor sigK also was prolonged in the integrants compared to that of the wild type; however, sigE expression was unchanged. Western blot analysis of σ(E) and σ(K) showed the prolonged accumulation of σ(E) in the integrants compared to that of BTA1, resulting in the increased synthesis of pro-σ(K) up to T(17) after the onset of sporulation in both BtaP19CS and BtaCAT compared to that of T(13) in BTA1. The results from qPCR indicate clearly that the cry1Aa promoter activity was influenced most strongly by σ(E), whereas cry11Aa depended mostly on σ(K). These results on large-crystal toxin formation with enhanced toxicity should provide useful information for the generation of strains with improved insecticidal activity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.